- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: mycophenolate mofetil
Total 960 results
-
Astellas Pharma IncCompletedBenign Prostate HyperplasiaJapan
-
Baylor Research InstituteActive, not recruitingAbsolute Uterine InfertilityUnited States
-
Columbia UniversityCompletedImplant or Graft; RejectionUnited States
-
Poitiers University HospitalCompletedChronic Kidney DiseaseFrance
-
Novartis PharmaceuticalsCompletedKidney TransplantationUnited States, United Kingdom, Germany, Belgium, Spain, Canada, Sweden
-
Ain Shams UniversityCompletedNon-stented Ureteroscopic Laser Lithotripsy for Ureteric StonesEgypt
-
Guy's and St Thomas' NHS Foundation TrustAstellas Pharma Europe Ltd.Unknown
-
M.D. Anderson Cancer CenterCompletedLeukemia | Hematologic Malignancies | Blood Stem Cell Transplant FailureUnited States
-
NovartisCompletedRenal Transplantation | Gastrointestinal ProblemsGermany, Switzerland
-
Boryung Pharmaceutical Co., LtdCompletedHypertension | DiabetesKorea, Republic of
-
Rafic Farah, MDCompletedLymphoma | Leukemia | Myelofibrosis | MDSUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedWolman Disease | Adrenoleukodystrophy | Metachromatic Leukodystrophy | Sanfilippo Syndrome | GM1 Gangliosidosis | Globoid Cell Leukodystrophy | Tay Sachs Disease | Sandhoffs Disease | I-Cell DiseaseUnited States
-
University of Wisconsin, MadisonTerminatedKidney TransplantationUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedSystemic Sclerosis-associated Interstitial Lung DiseaseUnited States, Canada, Italy, Poland, Spain, Argentina, Australia, Israel, United Kingdom
-
Ronaldo de Matos Esmeraldo, MDNovartis PharmaceuticalsCompletedCytomegalovirus Infections | Transplantation InfectionBrazil
-
Medical University of South CarolinaHoffmann-La RocheTerminated
-
The University of Hong KongCompleted
-
R. Mark Ghobrial, MDNovartisCompletedEnd Stage Liver DiseaseUnited States
-
Columbia UniversityPfizer; Cornell UniversityCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Stanford UniversityNational Cancer Institute (NCI); The Leukemia and Lymphoma SocietyCompletedLeukemia, Mast-Cell | Mantle-cell LymphomaUnited States
-
Yanbing LiUnknownType 2 Diabetes Mellitus | Peritoneal DialysisChina
-
Novartis PharmaceuticalsCompleted
-
Helio Tedesco Silva JuniorSanofi; NovartisCompletedKidney Transplantation | CytomegalovirusBrazil
-
Klemens BuddeCharite University, Berlin, Germany; DESCARTES Working Group On Transplantation and other collaboratorsUnknownImmunosuppression After Renal Transplantation
-
University of Michigan Rogel Cancer CenterAmgen; MallinckrodtCompletedGraft Versus Host DiseaseUnited States
-
Novartis PharmaceuticalsCompletedRenal TransplantKorea, Republic of
-
Novartis PharmaceuticalsCompleted
-
STZ eyetrialNovartis Pharmaceuticals; University Hospital TuebingenCompletedUveitis, IntermediateGermany
-
Novartis PharmaceuticalsCompleted
-
Asan Medical CenterSamsung Medical Center; Seoul National University HospitalCompletedKidney TransplantationKorea, Republic of
-
Profil Institut für Stoffwechselforschung GmbHCompletedDiabetes MellitusGermany
-
Novartis PharmaceuticalsWithdrawnKidney TransplantUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedPatients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS
-
NovartisCompletedRenal TransplantationSwitzerland
-
NovartisCompletedKidney TransplantationSwitzerland
-
Novartis PharmaceuticalsCompletedKidney TransplantationUnited States
-
Novartis PharmaceuticalsCompletedKidney TransplantationGermany, Switzerland
-
University of SaskatchewanWithdrawnCardiovascular Disease | Kidney Transplantation | Kidney Transplant Recipients | Cardiovascular OutcomesCanada
-
Gaetano CiancioCompletedTransplant; Failure, KidneyUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedSystemic Lupus ErythematosusSpain
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Bristol-Myers SquibbUnknownRheumatoid Arthritis (RA)China
-
University Health Network, TorontoBayerCompletedAlemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell TransplantsBone Marrow Transplantation | Graft Versus Host DiseaseCanada
-
University of UtahCompletedKidney TransplantationUnited States
-
Novartis PharmaceuticalsCompletedKidney Transplantation | GI Symptoms SeverityMalaysia